Literature DB >> 33919825

Spongostan Leads to Increased Regeneration of a Rat Calvarial Critical Size Defect Compared to NanoBone® and Actifuse.

Dirk Wähnert1, Julian Koettnitz1, Madlen Merten2, Daniel Kronenberg3, Richard Stange3, Johannes F W Greiner4, Christian Kaltschmidt4, Thomas Vordemvenne1, Barbara Kaltschmidt2,4.   

Abstract

Bone substitute materials are becoming increasingly important in oral and maxillofacial surgery. Reconstruction of critical size bone defects is still challenging for surgeons. Here, we compared the clinically applied organic bone substitute materials NanoBone® (nanocrystalline hydroxyapatite and nanostructured silica gel; n = 5) and Actifuse (calcium phosphate with silicate substitution; n = 5) with natural collagen-based Spongostan™ (hardened pork gelatin containing formalin and lauryl alcohol; n = 5) in bilateral rat critical-size defects (5 mm diameter). On topological level, NanoBone is known to harbour nanopores of about 20 nm diameter, while Actifuse comprises micropores of 200-500 µm. Spongostan™, which is clinically applied as a haemostatic agent, combines in its wet form both nano- and microporous topological features by comprising 60.66 ± 24.48 μm micropores accompanied by nanopores of 32.97 ± 1.41 nm diameter. Micro-computed tomography (µCT) used for evaluation 30 days after surgery revealed a significant increase in bone volume by all three bone substitute materials in comparison to the untreated controls. Clearly visual was the closure of trepanation in all treated groups, but granular appearance of NanoBone® and Actifuse with less closure at the margins of the burr holes. In contrast, transplantion of Spongostan™ lead to complete filling of the burr hole with the highest bone volume of 7.98 ccm and the highest bone mineral density compared to all other groups. In summary, transplantation of Spongostan™ resulted in increased regeneration of a rat calvarial critical size defect compared to NanoBone and Actifuse, suggesting the distinct nano- and microtopography of wet Spongostan™ to account for this superior regenerative capacity. Since Spongostan™ is a clinically approved product used primarily for haemostasis, it may represent an interesting alternative in the reconstruction of defects in the maxillary region.

Entities:  

Keywords:  bone regeneration; bone substitute materials; critical size defect; rat calvaria

Year:  2021        PMID: 33919825     DOI: 10.3390/ma14081961

Source DB:  PubMed          Journal:  Materials (Basel)        ISSN: 1996-1944            Impact factor:   3.623


  3 in total

Review 1.  Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.

Authors:  Arbi Aghali
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

2.  Human Sex Matters: Y-Linked Lysine Demethylase 5D Drives Accelerated Male Craniofacial Osteogenic Differentiation.

Authors:  Madlen Merten; Johannes F W Greiner; Tarek Niemann; Meike Grosse Venhaus; Daniel Kronenberg; Richard Stange; Dirk Wähnert; Christian Kaltschmidt; Thomas Vordemvenne; Barbara Kaltschmidt
Journal:  Cells       Date:  2022-02-26       Impact factor: 6.600

Review 3.  Strategies to Improve Bone Healing: Innovative Surgical Implants Meet Nano-/Micro-Topography of Bone Scaffolds.

Authors:  Dirk Wähnert; Johannes Greiner; Stefano Brianza; Christian Kaltschmidt; Thomas Vordemvenne; Barbara Kaltschmidt
Journal:  Biomedicines       Date:  2021-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.